98%
921
2 minutes
20
The Cognitive Functions Dementia (CFD) is a computerized battery to assess the cognitive domains included in the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) criteria for neurocognitive disorders. We aimed at examining the psychometric properties and the clinical validity of the CFD for neurocognitive disorders. Psychometric characterization was conducted in healthy individuals, stratified according to age, sex, and education to represent a norming sample. Analyses included structural validity and measurement invariance, assessed through confirmatory factor analyses (CFA) and multi-group CFA, as well as internal consistency, and re-test reliability of the battery index values. Patients with major or minor neurocognitive disorder contributed data to compute receiver operating characteristics to assess diagnostic accuracy of the CFD indices relative to healthy participants. Data from 422 healthy volunteers and 81 patients were collected for the study. The confirmatory factor analysis model confirmed the validity of the structure proposed for CFD, with the five cognitive domains (attention, verbal long-term memory, expressive language, executive functions, and perceptual motor functions) describing an overall factor (CFD-Index). Good to excellent values of internal consistency and of re-test reliability were obtained for all indices. Importantly, CFD indexes were accurate in discriminating patients with neurocognitive disorders from healthy participants. The CFD battery is a valid and reliable computerized instrument to characterize patients with neurocognitive dysfunction.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.14336/AD.2025.0412 | DOI Listing |
JAMA Netw Open
September 2025
Critical Illness, Brain Dysfunction, and Survivorship Center, Vanderbilt University Medical Center, Nashville, Tennessee.
Importance: Survivors of critical illness often have ongoing issues that affect functioning, including driving ability.
Objective: To examine whether intensive care unit (ICU) delirium is independently associated with long-term changes in driving behaviors.
Design, Setting, And Participants: This multicenter, longitudinal cohort study included 151 survivors of critical illness residing within 200 miles of Nashville, Tennessee.
Background: People with dementia who have a fall can experience both physical and psychological effects, often leading to diminished independence. Falls impose economic costs on the healthcare system. Despite elevated fall risks in dementia populations, evidence supporting effective home-based interventions remains limited.
View Article and Find Full Text PDFMetab Brain Dis
September 2025
Department of Neuroscience, Faculty of Advanced Medical Sciences, Tabriz University of Medical Sciences, Tabriz, Iran.
Brain ischemia is a major global cause of disability, frequently leading to psychoneurological issues. This study investigates the effects of 4-aminopyridine (4-AP) on anxiety, cognitive impairment, and potential underlying mechanisms in a mouse model of medial prefrontal cortex (mPFC) ischemia. Mice with mPFC ischemia were treated with normal saline (NS) or different doses of 4-AP (250, 500, and 1000 µg/kg) for 14 consecutive days.
View Article and Find Full Text PDFEur J Neurosci
September 2025
Institute of Public Health, Riga Stradiņš University, Riga, Latvia.
Evidence suggests that working memory (WM) capacity decreases with age, resulting in cognitive decline. Given the link between aging and reduced hippocampal volume, this study examined whether and how hippocampal volume is associated with WM. 46 participants aged 65-85 years (Mage = 71.
View Article and Find Full Text PDFAlzheimers Dement
September 2025
Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Introduction: Mutations in SORL1, encoding the sorting receptor Sortilin-related receptor with A-type repeats (SORLA), are found in individuals with Alzheimer's disease (AD). We studied SORLA, carrying a mutation in its ligand binding domain, to learn more about receptor functions relevant for human brain health.
Methods: We investigated consequences of SORLA expression in induced pluripotent stem cell (iPSC)-derived human neurons and microglia, using unbiased proteome screens and functional cell assays.